Cochlear Limited operates in the Electromedical equipment sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Cochlear Limited with three other
medical equipment manufacturers in Australasia:
Compumedics Limited
(2020
sales of 35.07 million Australian Dollars [US$27.04 million]
of which 43%
was Australia and Asia Pacific),
Nanosonics Limited
(100.05 million Australian Dollars [US$77.14 million]
), and
Mach7 Technologies Ltd
(18.86 million Australian Dollars [US$14.54 million]
of which 58%
was Software licenses).
Sales Analysis.
Cochlear Limited reported sales of A$1.32 billion (US$1.02 billion)
for the
fiscal
year ending
June of 2020.
This
represents
a
decrease of 7.4%
versus 2019, when the company's sales were A$1.43 billion.
Contributing to the drop in overall sales was the 7.6% decline
in Emea, from A$519.20 million to A$479.60 million.
There were also decreases in sales in
Americas (down 5.6% to A$650.30 million)
and
Asia Pacific (down 6.7% to A$222.40 million)
.